Immunomedics Inc file registration statement Securities Exchange Commission propose sale 2500000 share common stock. The company sell 2100000 share stockholder sell remain 400000 shares. Proceeds offering product development basic research staff expansion prepayment debt capital expenditure work capital company said. The offering co-managed E.F. Hutton Co Inc First Boston Corp Immunomedics said. Reuter 